RecruitingPhase 2NCT05778188
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
Studying Neonatal hypoxic and ischemic brain injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ReAlta Life Sciences, Inc.
- Intervention
- RLS-0071(drug)
- Enrollment
- 70 enrolled
- Eligibility
- All sexes
- Timeline
- 2023 – 2026
Study locations (15)
- Study Site 016, Little Rock, Arkansas, United States
- Study Site 013, Orange, California, United States
- Study Site 020, San Diego, California, United States
- Study Site 019, San Diego, California, United States
- Study Site 001, Gainesville, Florida, United States
- Study Site 018, Miami, Florida, United States
- Study Site 010, Orlando, Florida, United States
- Study Site 014, Indianapolis, Indiana, United States
- Study Site 012, Lexington, Kentucky, United States
- Study Site 002, Boston, Massachusetts, United States
- Study Site 006, St Louis, Missouri, United States
- Study Site 003, Durham, North Carolina, United States
- Study Site 021, Cleveland, Ohio, United States
- Study Site 022, Fort Worth, Texas, United States
- Study Site 005, Morgantown, West Virginia, United States
Collaborators
Premier Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05778188 on ClinicalTrials.govOther trials for Neonatal hypoxic and ischemic brain injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07464938New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac ArrestCliniques universitaires Saint-Luc- Université Catholique de Louvain
- ENROLLING BY INVITATIONNCT07264166Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)Healing Hope International
- ENROLLING BY INVITATIONPHASE1NCT06429007A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain InjuryBoston Children's Hospital
- RECRUITINGNANCT06762795The HIEnome Study: Genome Sequencing for Perinatal HIEBaylor College of Medicine
- RECRUITINGNCT07136636Speech of Kids After Neonatal EncephalopathySemmelweis University
- RECRUITINGEARLY PHASE1NCT06746532Intranasal Breast Milk Therapy in HIESemmelweis University
- RECRUITINGEARLY PHASE1NCT06747260Feasibility and Safety of Intranasally Administered Breast Milk in HIESemmelweis University
- RECRUITINGNANCT06563687Continuous Glucose Monitoring in HIEUniversity of Campania Luigi Vanvitelli
See all trials for Neonatal hypoxic and ischemic brain injury →